Angel Yeast (Yichang, Hubei, China), a globally listed yeast and yeast extract manufacturer, has inked an agreement with Bejing based PhaBuilder Biotechnology (China) to build a large manufacturing base for polyhydroxyalkanoates (PHA) in Yichang. The pair will set up a joint venture company to drive the application of synthetic biology in the biotechnology industry.
PHA is a polyester produced naturally by microorganisms. The biodegradable and biocompatible properties of PHA make it highly sought-after in fields such as biomedical material and biodegradable packaging material.
“This collaboration with PhaBuilder marks a milestone and a significant step forward for Angel Yeast in synthetic biology. At Angel Yeast, we are very keen on innovation and exploration of new landscapes in the industry. This project is also part of our efforts to be an international and professional biotechnology company”, said Tao Xiong, chairman of Angel Yeast.
He added that the partnership is expected to forge a new venture in bioeconomy, fuel innovation in synthetic biology, and drive the expansion of the global market.
Guoqiang Chen, the founder of PhaBuilder, added that by working with Angel Yeast on the initiative, major inroads have been made in converting technology breakthroughs into industrial programs for synthetic biology.
“The new production line of PHA with the capacity of 30,000 tonnes will certainly bring more advanced technologies, new services and products for the industry and consumers. It will also create a ‘greener’ lifestyle. We are thrilled to see it happen”, said Chen.
PhaBuilder invested about EUR 150 million in the new NGIB (Next Generation Industrial Biotechnology) based PHA plant, which is planned to go operational in the last quarter of 2023.